Código QR (código de barras bidimensional)

Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

Abstract Background Triple therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who remain symptomatic despite dual therapy. The optimal timing of triple therapy following an exacerbation of COPD is unknown. The outcomes of prompt (≤ 30 days) vs. delayed (31–180 days...

Fuld beskrivelse

Na minha lista:
Principais autores: Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey, David M. G. Halpin
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2023-09-01
Serier:Respiratory Research
Fag:
Chronic obstructive pulmonary disease
Exacerbation
FF/UMEC/VI
Healthcare cost
SITT
Online adgang:https://doi.org/10.1186/s12931-023-02523-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker